IRIS - Res&Arch Institutional Research Information System - Research & Archive

FALINI, Brunangelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.347
EU - Europa 6.045
AS - Asia 2.254
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 8
AF - Africa 6
OC - Oceania 6
Totale 15.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.302
IE - Irlanda 1.337
IT - Italia 1.306
UA - Ucraina 1.147
SE - Svezia 988
SG - Singapore 786
HK - Hong Kong 466
VN - Vietnam 465
FI - Finlandia 343
CN - Cina 327
DE - Germania 265
RU - Federazione Russa 245
GB - Regno Unito 145
KR - Corea 91
TR - Turchia 60
FR - Francia 58
CH - Svizzera 49
CA - Canada 35
BE - Belgio 33
AT - Austria 26
UZ - Uzbekistan 26
CZ - Repubblica Ceca 24
NL - Olanda 22
PL - Polonia 21
GR - Grecia 14
LB - Libano 12
EU - Europa 8
ES - Italia 7
IN - India 7
MX - Messico 7
JP - Giappone 6
BR - Brasile 5
RO - Romania 5
IL - Israele 4
AU - Australia 3
CI - Costa d'Avorio 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
EC - Ecuador 2
PA - Panama 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BO - Bolivia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
IM - Isola di Man 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
PT - Portogallo 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 15.675
Salva come PNG Salva come JPEG
Città #
Chandler 1.507
Dublin 1.337
San Mateo 715
Singapore 614
Jacksonville 611
Perugia 531
Boardman 506
Dong Ket 465
Hong Kong 465
Santa Clara 352
Altamura 333
Medford 302
Princeton 297
Wilmington 248
Lawrence 232
Ann Arbor 201
Andover 197
Beijing 127
Des Moines 95
Helsinki 92
Seoul 90
Saint Petersburg 85
Ashburn 73
Norwalk 67
Izmir 59
Shanghai 51
Los Angeles 50
Woodbridge 49
Falls Church 47
Dallas 43
New York 41
San Paolo di Civitate 41
Redmond 35
Brussels 33
Munich 28
Ottawa 28
Rome 28
Redwood City 27
Houston 24
Moscow 20
Dearborn 19
Foligno 18
Auburn Hills 16
Ficarazzi 13
Den Haag 11
Terni 11
Chicago 10
Brno 7
Lappeenranta 7
Olomouc 7
Philadelphia 7
San Diego 7
Tappahannock 7
Amelia 6
Florence 6
Frankfurt am Main 6
Guangzhou 6
Lausanne 6
Brescia 5
Collazzone 5
Madrid 5
Nanning 5
Simi Valley 5
Verona 5
Amsterdam 4
Duncan 4
Frankfurt Am Main 4
Kraków 4
London 4
Milan 4
Tivoli 4
Tokyo 4
Trieste 4
Abidjan 3
Assisi 3
Aurora 3
Basel 3
Bologna 3
Bucharest 3
Cambridge 3
Edinburgh 3
Fairfield 3
Fremont 3
Gradara 3
Nürnberg 3
Padova 3
Paris 3
Prata Di Pordenone 3
Scafa 3
Vienna 3
Bacoli 2
Belgioioso 2
Boydton 2
Brasília 2
Campobasso 2
Changsha 2
Chaoyang 2
Cornedo Vicentino 2
Essen 2
Falkenstein 2
Totale 10.453
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 113
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 109
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. 104
Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction. 98
Acute leukaemia immunophenotyping in bone-marrow routine sections. 96
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 96
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 96
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 95
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 93
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 91
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells 90
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. 89
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 89
A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. 88
Anaplastic large cell lymphoma: pathological, molecular and clinical features. 87
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 86
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features 86
Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita 86
The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissues. 85
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 85
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance 84
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 83
Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification 82
Primay large B-cell lymphoma (PLBCL) of the retroperitoneum: a heterogeneous group of neoplasms, some of which mimic PLBCL of the mediastinum. 80
Genomics of Hairy cell leukemia 80
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 79
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 79
Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas 77
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia 77
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 77
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT) 76
Aggressive lymphomas: a convenient concept or an anatomo-pathological reality? 76
Minimal residual disease levels assessed by NPM1 mutation specific RQ-PCR provide important prognostic information in AML. 76
Nucleophosmin regulates the stability and transcriptional activity of p53. 75
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics] 75
Aberrant hypermutation of PIM1, PAX5, RhoH/TTF and cMYC in nodular lymphocyte predominance Hodgkin's disease 75
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 75
Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma. 74
TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. 74
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 74
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease 73
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 73
Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family. 72
Detection of normal and chimeric nucleophosmin in human cells. 72
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 72
CHARACTERIZATION OF A NEW MONOCLONAL ANTIBODY (PG-M3) DIRECTED AGAINST THE AMINOTERMINAL PORTION OF THE PML GENE PRODUCT: IMMUNOCYTOCHEMICAL EVIDENCE FOR HIGH EXPRESSION OF PML PROTEINS ON ACTIVATED MACROPHAGES, ENDOTHELIAL CELLS, AND EPITHELIA 71
Any role for the nucleophosmin (NPM1) gene in myelodysplastic syndromes and acute myeloid leukemia with chromosome 5 abnormalities? 71
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 71
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy 71
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. 70
Acute Myeloid Leukemia with mutated nucleophosmin (NPM1). Any hope for a targeted therapy? 70
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 70
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 70
Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity 69
Nucleophosmin is required for DNA integrity and p19Arf protein stability. 69
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 69
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 69
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. 69
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. 67
Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia 67
T regulatory cell separation for clinical application. 67
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 67
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 66
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 66
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 66
Mutant NPM1 Maintains the Leukemic State through HOX Expression 66
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma 66
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases 65
Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma. 65
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 65
Evolving concepts in the pathogenesis of hairy-cell leukaemia. 65
NPM1-mutated AML: targeting by disassembling 65
Mutational landscape of AML with normal cytogenetics: biological and clinical implications 65
BRAF mutations in hairy-cell leukemia. 65
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 65
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice. 64
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 64
Prognostic impact of genetic characterization in the GIMEMA LAM99P study for newly diagnosed adult AML. Relevance of combined analysis of conventional karyotyping, FLT3 and NPM mutational status 63
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 63
Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia 63
null 63
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity 63
Gene expression analysis of peripheral T-cell lymphoma not otherwise specified reveals the existance of two subgroups related to different cellular counterparts and recurrent PDGFRA deregulation 62
Coinvolgimento cutaneo da leucosi acuta mieloide con dislocazione citoplasmatica di nucleofosmina (sarcoma mieloide NPMc+) 62
Antigen retrieval techniques in immunohistochemistry: comparison of different methods 62
Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation. 61
Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23). 61
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. 61
"Designed" grafts for HLA-haploidentical stem cell transplantation. 61
Coinvolgimento cutaneo da leucosi acuta mieloide con dislocazione citoplasmatica di nucleofosmina (sarcoma mieloide NPMc+) 61
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 61
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 61
Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells. 61
ARPIR: automatic RNA-Seq pipelines with interactive report 61
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 60
Beta-HCG aberrant expression in primary mediastinal large B-cell lymphoma. 60
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 59
A case of JAK2 V617F-positive myelodisplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 59
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 59
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 59
Totale 7.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020910 0 0 0 0 148 26 156 41 196 165 28 150
2020/20212.818 10 170 115 170 735 202 180 56 324 102 229 525
2021/20222.962 70 550 79 184 109 41 30 785 71 161 452 430
2022/20234.805 333 868 48 405 388 537 6 220 1.716 62 165 57
2023/20241.763 128 194 102 48 18 20 406 30 151 53 303 310
2024/20251.536 132 477 182 152 593 0 0 0 0 0 0 0
Totale 16.530